Research ArticleArticle
NONLINEAR ORAL PHARMACOKINETICS OF THE α-ANTAGONIST 4-AMINO-5-(4-FLUOROPHENYL)-6,7-DIMETHOXY-2-[4-(MORPHOLINOCARBONYL)-PERHYDRO-1,4-DIAZEPIN-1-YL]QUINOLINE IN HUMANS: USE OF PRECLINICAL DATA TO RATIONALIZE CLINICAL OBSERVATIONS
Anthony Harrison, Alison Betts, Katherine Fenner, Kevin Beaumont, Alan Edgington, Sarah Roffey, John Davis, Pierre Comby and Paul Morgan
Drug Metabolism and Disposition February 2004, 32 (2) 197-204; DOI: https://doi.org/10.1124/dmd.32.2.197
Anthony Harrison
Alison Betts
Katherine Fenner
Kevin Beaumont
Alan Edgington
Sarah Roffey
John Davis
Pierre Comby
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Drug Metabolism and Disposition
Vol. 32, Issue 2
1 Feb 2004
Research ArticleArticle
NONLINEAR ORAL PHARMACOKINETICS OF THE α-ANTAGONIST 4-AMINO-5-(4-FLUOROPHENYL)-6,7-DIMETHOXY-2-[4-(MORPHOLINOCARBONYL)-PERHYDRO-1,4-DIAZEPIN-1-YL]QUINOLINE IN HUMANS: USE OF PRECLINICAL DATA TO RATIONALIZE CLINICAL OBSERVATIONS
Anthony Harrison, Alison Betts, Katherine Fenner, Kevin Beaumont, Alan Edgington, Sarah Roffey, John Davis, Pierre Comby and Paul Morgan
Drug Metabolism and Disposition February 1, 2004, 32 (2) 197-204; DOI: https://doi.org/10.1124/dmd.32.2.197
Research ArticleArticle
NONLINEAR ORAL PHARMACOKINETICS OF THE α-ANTAGONIST 4-AMINO-5-(4-FLUOROPHENYL)-6,7-DIMETHOXY-2-[4-(MORPHOLINOCARBONYL)-PERHYDRO-1,4-DIAZEPIN-1-YL]QUINOLINE IN HUMANS: USE OF PRECLINICAL DATA TO RATIONALIZE CLINICAL OBSERVATIONS
Anthony Harrison, Alison Betts, Katherine Fenner, Kevin Beaumont, Alan Edgington, Sarah Roffey, John Davis, Pierre Comby and Paul Morgan
Drug Metabolism and Disposition February 1, 2004, 32 (2) 197-204; DOI: https://doi.org/10.1124/dmd.32.2.197
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement